Program Committee

Bob Ames, GSK, USA
Richard Eglen, PerkinElmer, USA
Frank Fan, Promega Corporation, USA
Tom Kost, GSK, USA
Jeff Paslay, Wyeth Research, USA
Jennings Worley, Vertex Pharmaceuticals, USA